Sharing our partnering experience and expertise
Through a series of video ‘tutorials’, our business development colleagues are sharing their expertise in identifying, negotiating and sustaining collaborations that create... Learn More
Respiratory disease – How can AstraZeneca make a difference?
Hear more from the talent of AstraZeneca who contribute to our commitment to respiratory disease. Our 40-year heritage in respiratory science is... Learn More
IMED Science Retreat 2018 – overview
Hear from Mene Pangalos, Executive Vice-President, IMED Science Unit and Global Business Development.
IMED Science Retreat 2018 – collaboration
Hear from Bert Rutten, Senior Research Scientist, Precision Medicine & Genomics, IMED Science Unit.
Operations at AstraZeneca: delivering our science to patients
Operations at AstraZeneca brings innovation from our science labs to patients, touching every part of the business. As such, we have a... Learn More
Post Doc programme: Discover how far you can take your science
Learn more about our Post Doc programmes in the US, UK or Sweden: https://bit.ly/2qsYU3b
Trailer – Bicycle Therapeutics – AstraZeneca collaboration
This is the trailer for this video – https://youtu.be/lRrMcggeoGU. AstraZeneca and Bicycle Therapeutics have collaborated to develop a new type of small... Learn More
Trailer – Microsoft Research and AstraZeneca – BioModel Analyzer
This is the trailer for this video: https://youtu.be/0OEvk79JW78. AstraZeneca is working with Microsoft Research and the University of Cambridge to analyse cell... Learn More
Trailer – Cancer Research UK (CRUK) – MedImmune Alliance Laboratory
This is the trailer for this video https://youtu.be/7oEnAzqnnII. Cancer Research UK and MedImmune have collaborated to form a lab focused on oncology.... Learn More
Cancer Research UK (CRUK) – MedImmune Alliance Laboratory
Cancer Research UK and MedImmune have collaborated to form a lab focused on oncology. Film contains descriptive information only.
Bicycle Therapeutics – AstraZeneca collaboration
AstraZeneca and Bicycle Therapeutics have collaborated to develop a new type of small and agile antibody called “bicyclic peptides”. Film contains descriptive... Learn More
Microsoft Research and AstraZeneca – BioModel Analyzer
AstraZeneca is working with Microsoft Research and the University of Cambridge to analyse cell behaviour patterns using cloud-based modelling software. Film contains... Learn More
Advancing patient care in neurodegenerative diseases with unmet medical needs
With a rich heritage and a research and development focus on specific aspects of neurodegenerative diseases, analgesia and psychiatry, AstraZeneca continues to... Learn More
International Women’s Day – Women leaders in manufacturing
Women leaders at AstraZeneca Macclesfield on manufacturing and inspiring the next generation.
Ensuring the environmental safety of our products
We are committed to ensuring effective environmental management of our products from pre-launch through to product end-of-life. Our aim is to lead... Learn More
2017 World Diabetes Day Highlights
Thank you to our teams who are committed to serving the diabetes community year-round, and especially on World Diabetes Day! Here are... Learn More
AZ Young Scientists – Yannick Morias
AstraZeneca and MedImmune, our global biologics research and development arm, have been voted one of the top science employers worldwide, in the... Learn More
AZ Young Scientists – Nitin Agarwal
AstraZeneca and MedImmune, our global biologics research and development arm, have been voted one of the top science employers worldwide, in the... Learn More
AZ Young Scientists – Mark Williams
AstraZeneca and MedImmune, our global biologics research and development arm, have been voted one of the top science employers worldwide, in the... Learn More
AZ Young Scientists – Lucy Riches
AstraZeneca and MedImmune, our global biologics research and development arm, have been voted one of the top science employers worldwide, in the... Learn More
AZ Young Scientists – Lauryn Klevorn
AstraZeneca and MedImmune, our global biologics research and development arm, have been voted one of the top science employers worldwide, in the... Learn More
AZ Young Scientists – Duong Nguyen
AstraZeneca and MedImmune, our global biologics research and development arm, have been voted one of the top science employers worldwide, in the... Learn More
AZ Young Scientists – Daniel O’Neil
AstraZeneca and MedImmune, our global biologics research and development arm, have been voted one of the top science employers worldwide, in the... Learn More
AZ Young Scientists – Ben Ruddle
AstraZeneca and MedImmune, our global biologics research and development arm, have been voted one of the top science employers worldwide, in the... Learn More
Rethinking cardiovascular disease prevention
As a global community, we have the tools to prevent CVD on a worldwide scale, but how do we ensure this knowledge... Learn More
Our commitment to respiratory disease
Recent developments in the understanding of respiratory disease pathways mean that we are entering an era of unprecedented potential to deliver scientific... Learn More
Because of Our People. This is AstraZeneca Gothenburg.
The Gothenburg site is one of AstraZeneca’s three global strategic research and development centres and home to our more than 2,500 colleagues... Learn More
This is us. This is AstraZeneca Gothenburg.
This is us. This is AstraZeneca Gothenburg. The Gothenburg site is one of AstraZeneca’s three global strategic research and development centres and... Learn More
AstraZeneca Exchange Gothenburg
Our aim with AstraZeneca Exchange Gothenburg is to support the growing Life Science ecosystem in the Nordics, stimulate innovation and make the... Learn More
World Ovarian Cancer Day 2017
8 May 2017 is World Ovarian Cancer Day. Find out more at http://ovariancancerday.org
Our Immuno-Oncology Pipeline
We aim to improve the lives of patients through innovative treatments like #immunoOncology, working to eliminate #cancer as a cause of death
Our Immuno-Oncology Ambition
We’re using #ImmunoOncology to help fight #bladdercancer, the 9th most common #cancer worldwide.
Where science lives
Short video about our (AstraZeneca and MedImmune) Gaithersburg campus (Maryland, US).
Foundation Medicine and AstraZeneca
Collaborating to bring personalised treatments to cancer patients
A game-changing scientific collaboration: Charles River and AstraZeneca
AstraZeneca and Charles River share a passion for ground-breaking scientific research. Our partnership is focused on accelerating the delivery of new medicines.... Learn More
Partnership with Max Planck Institute of Molecular Physiology
We have been partnering with the Max-Planck Society and consortium companies for several years. In 2014, we established a chemistry ‘satellite unit’... Learn More
Bahija Jallal speaks at UN Women and Girl’s in Science Day 2017
Bahija Jallal, representing AstraZeneca & MedImmune and the Association for Woman in Science was a featured speaker at the second annual International... Learn More
Guangzhou Medical University & AstraZeneca: Advancing understanding of COPD in China
We’re working with Guangzhou Medical University, one of the world’s leading centres for research into respiratory disease, to advance the scientific understanding... Learn More
University of Virginia and AstraZeneca: In search of novel cardiometabolic therapies
We are working with the University of Virginia to develop innovative treatments for cardiovascular disease. The partnership supports preclinical to clinical research... Learn More
Dr. Sosale on the DISCOVER Study
This video was produced by AstraZeneca. DISCOVER is a global observational study of patients with type 2 diabetes mellitus who are starting... Learn More
Professor Shestakova on the DISCOVER Trial
This video was produced by AstraZeneca. DISCOVER is a global observational study of patients with type 2 diabetes mellitus who are starting... Learn More
Professor Kosiborod on the DISCOVER Study
This video was produced by AstraZeneca. DISCOVER is a global observational study of patients with type 2 diabetes mellitus who are starting... Learn More
Professor Ji on the DISCOVER Study
This video was produced by AstraZeneca. DISCOVER is a global observational study of patients with type 2 diabetes mellitus who are starting... Learn More
Dr. Hay on the DISCOVER Study
This video was produced by AstraZeneca. DISCOVER is a global observational study of patients with type 2 diabetes mellitus who are starting... Learn More
Dr. Fulat on the DISCOVER Study
This video was produced by AstraZeneca. DISCOVER is a global observational study of patients with type 2 diabetes mellitus who are starting... Learn More
Dr. Pereira on the DISCOVER Study
This video was produced by AstraZeneca. DISCOVER is a global observational study of patients with type 2 diabetes mellitus who are starting... Learn More
ON Helix translational research event 2016
Listen to why Cambridge UK is a key place for life sciences, via the ON Helix translational research event on 28 June... Learn More
MedImmune – join the conversation
Find out about life at Medimmune as employees from around the world join the conversation.
Nagoya Protocol – Compliance and R&D at AstraZeneca
AstraZeneca upholds the principles of the Nagoya Protocol, an international agreement to protect the benefits enjoyed by the country of origin of... Learn More
Sanger Institute-AstraZeneca CRISPR conference
With over 250 attendees, the Sanger Institute-AstraZeneca CRISPR conference held 17-19 January 2016 in Cambridge, UK, was a great success. The community... Learn More
Young Health Programme Kenya
An animated showreel highlighting the environmental challenges facing young people living in the Kibera slums in Nairobi
Lost Generation Poem
Effective management of diabetes can lead to a bright future and long and healthy life.
Lives Impacted By Diabetes Worldwide
How many lives were impacted by diabetes in 2014? In this video you can find out what this number means and how... Learn More
Claude Sokolowsky interview
Extract from an interview given by Claude Sokolowsky, President of the Association Française des Diabétiques, during the Global Diabetes Policy Summit. Find... Learn More
Dr Abdulrazzaq Almadani interview
Extract from an interview given by Dr Abdulrazzaq Almadani, Chairman of the Emirates Diabetes Society, at the Global Diabetes Policy Summit. Find... Learn More
Rick Blickstead interview
Extract from an interview given by Rick Blickstead, President and CEO of the Canadian Diabetes Association, at the Global Diabetes Policy Summit.... Learn More
Dr Nicky Lieberman interview
Extract from an interview given by Dr Nicky Lieberman , Head of the Community Medicine Division at Clalit Health Services, during the... Learn More
Prof Kamlesh Khunti interview
Extract from an interview given by Prof Kamlesh Khunti, Professor of Primary Care Diabetes & Vascular Medicine at the University of Leicester,... Learn More
YHP Spain
The Young Health Programme Spain is focused on helping to improve the lives of young people in Madrid, enabling them to integrate... Learn More
AstraZeneca – What science can do
We push the boundaries of science to deliver life-changing medicines
Cambridge Biomedical Campus fly-through animation
AstraZeneca’s new Global R&D Centre and Corporate Headquarters in Cambridge, UK will be located on the Cambridge Biomedical Campus (CBC). This... Learn More
YHP showreel
A short image/text only showreel which outlines the Young Health Programme and achievements to date.
Global Medicines Development: The science engine room for our late stage development pipeline
AstraZeneca’s Global Medicines Development unit transforms clinical concepts into medicines that deliver patient health benefits. Here’s how they do it.
Young Voices – YHP India
These are some of the stories from young people in our YHP India programme, living in resettlement areas outside Delhi.
Suraj’s Story – YHP India
This is the story of Suraj who has been involved with the YHP in India for over four years.
Inspiring life science entrepreneurship in Cambridge
Watch the video on our entrepreneurial collaboration with Cambridge Judge Business School. The ‘Accelerate Cambridge’ Life Sciences programme aims to identify, train... Learn More
Young Health Programme NCD video
AstraZeneca’s Young Health Programme has a unique focus on young people and primary prevention of the most common non-communicable diseases (NCDs), such... Learn More
GLAZgo Discovery Centre: A uniquely close and agile industry-academia collaboration
The GLAZgo Discovery Centre is a unique collaborative venture established by AstraZeneca and the University of Glasgow. Together, we are exploring new... Learn More
Giving Youth a Voice
An AstraZeneca Young Health Programme film advocating for the engagement of young people in the development of policies and programming affecting their... Learn More
YHP 3 Years On Video
A retrospective film which shows the impact of the AstraZeneca Young Health Programme [2010 – 2013].
Prof John Weinman: The psychology behind non-adherence
In this video Professor John Weinman discusses the current problem with non-adherence to treatments, some of the psychological barriers behind that and... Learn More
X-Chem and AstraZeneca: Using technology to identify lead molecules faster
Since 2012, we’ve been working with US-based X-Chem Inc. to improve the rate and quality of small molecule lead discovery and expand... Learn More
Working with MRC to give UK academia access to AstraZeneca compounds
In 2011, a landmark agreement between MRC and AstraZeneca gave UK academic researchers unprecedented access to 22 of our compounds. These compounds... Learn More
CRISPR technology for genome editing
CRISPR, a pioneering genome-editing technique, technology will allow AstraZeneca to identify and validate new drug targets in preclinical models that closely resemble... Learn More
Heptares and AstraZeneca: Combining forces in novel approach to drug discovery
Heptares Therapeutics is a pioneer in G protein-coupled receptors structure-based drug design. By combining their expertise and technologies with AstraZeneca’s drug discovery... Learn More
Horizon Discovery & AstraZeneca: Searching for novel, personalised cancer therapies
At AstraZeneca, our bold ambition is to transform the lives of people with cancer and to one day help eliminate cancer as... Learn More
Pharmaron and AstraZeneca: Working together to accelerate drug discovery
AstraZeneca’s collaboration with Pharmaron, a leading R&D service provider in Beijing, China, has been going strong for over 2 years. Pharmaron works... Learn More
Healthy Heart Africa: Why is it important to tackle hypertension in Africa?
AstraZeneca has launched the Healthy Heart Africa programme aimed at tackling the burden of hypertension in Africa. Healthy Heart Africa is designed... Learn More
AstraZeneca and Petrov Institute: Leading personalised cancer research in Russia
AstraZeneca collaborates with hundreds of academic institutions across the globe, in an effort to bring novel medicines to patients faster. Our scientists... Learn More
AstraZeneca reveals designs for new Global R&D Centre and Corporate Headquarters in Cambridge, UK
AstraZeneca today revealed the proposed designs for its new Global R&D Centre and Corporate Headquarters in Cambridge in the UK. The plans... Learn More
AstraZeneca and MRC to create new UK Centre for Lead Discovery
On 31 March 2014, AstraZeneca and the Medical Research Council (MRC) announced that they have entered into a groundbreaking collaboration aimed at... Learn More